51860-Ardeshir Larijani, Fatemeh
Fellow

Fatemeh Ardeshir Larijani, MD

PGY 5

Phone 317-948-6942
Address
Indiana Cancer Pavilion
535 Barnhill Dr., Suite 473

Indianapolis, IN 46202-5289

Bio

completed my internal medicine training at Case Western Reserve University before starting my fellowship at Indiana University. My long-term plan is to stay in academia, focusing on thoracic oncology. My main interest sits in early phase clinical trial design and drug development.

Key Publications

KMT2D mutation is associated with poor prognosis in non-small cell lung cancer. Clinical Lung cancer journal, March 16.2018. Fatemeh Ardeshir-Larijani, MD, Priyanka Bhateja, Mary Beth Lipka, Neelesh Sharma, Pingfu Fu, Afshin Dowlati. MID: 29627316, DOI: 10.1016/j.cllc.2018.03.005

Retinoblastoma mutation predicts poor outcomes in non-small cell lung cancer (NSCLC). Cancer Medicine, Priyanka Bhateja MD, Gary Wildey PHD, Pingfu Fu PHD, Mary Beth Lipka MPH, Fatemeh Ardeshir-Larijani MD, Neelesh Sharma MD, Afshin Dowlati MD. PMID: 30773851, PMCID: PMC6488103, DOI: 10.1002/cam4.2021

Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer – Utilization Based on Race and Impact on Survival. Clinical Lung Cancer Journal,8/17/2020. Asrar Alahamdi, MD, Fatemeh Ardeshir-Larijani, MD, Pingfu Fu, PhD, Gary Wildey, PhD, Neelesh Sharma, M,D, PhD, Afshin Dowlati, MD. PMID: 33397584, DOI: 10.1016/j.cllc.2020.08.004

Clinico-genomic characterization of metastatic thymic epithelial tumors. F Ardeshir-Larijani, M Radovich, BP Schneider, PJ Loehrer. Journal of Clinical Oncology 39 (15_suppl), 8579-8579-2021

Phase II trial of atezolizumab (A)+ carboplatin (C)+ pemetrexed (P)+ bevacizumab (B) in pts with stage IV non-squamous non-small cell lung cancer (NSq-NSCLC): Big Ten Cancer Consortium Study LUN 17-139. Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, Lawrence Eric Feldman, Taher Abu Hejleh, Malini Patel, Ryan D Gentzler, Adam Ryan Miller, Nasser H HannaJournal of Clinical Oncology -39 (15_suppl), 9034-9034-2021

Impact of BRAF mutations on outcomes in metastatic melanoma with central nervous system metastases treated with immune checkpoint inhibitors.H De Sa, D Dedousis, SH Tirumani, F Ardeshir-Larijani, AA Nelson,  Petra Martin, Prateek Mendiratta, Andrew E Sloan, Serah Choi, David B Mansur, Jennifer Eva Selfridge, Nikhil H Ramaiya, Christopher J Hoimes .Journal of Clinical Oncology 39 (15_suppl), e21500-e21500-2021

Frequency of NOTCH pathway mutation in primary tumor of SCLC compared to metastatic biopsies and association with better survival. Fatemeh Ardeshir-Larijani, Gary Wildey, Pingfu Fu, Priyanka Bhateja, Afshin Dowlati. Journal of Clinical Oncology 36 (15_suppl), e20574-e20574-2018

Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy. F Ardeshir-Larijani, AA Nelson, P Martin, P Mendiratta, AE Sloan, S Choi, ...Journal of Clinical Oncology 37 (15_suppl), e21028-e21028-2019

Patients with limited stage small cell lung cancer that recur with isolated brain metastasis have prolonged survival. Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i21 

Titles & Appointments

  • Resident Appointee
  • Education
    2012 MD Tehran University of Medical Sciences
  • Research
    Active Research

    Defining the targetable genomic pathways and proteomics of metastatic thymic epithelial tumors as a bridge for new drug development in this subset of patients.

    Enhancing innate immunity (cGAs-STING pathway) in small cell lung cancer by targeting the DNA repair pathway. 

    Phase II trial of atezolizumab + carboplatin + pemetrexed + bevacizumab in pts with stage IV non-squamous non-small cell lung cancer.
  • Awards
    Org: American Society of Clinical Oncology
    Desc: Merit Award - Metastatic Thymic Tumor
    Scope: National
    Date: 2021-06-01
    Org: Indiana University
    Desc: Hematology/Oncology Fellowship Alumni Award
    Scope: Division
    Date: 2021-04-01
    Org: American Society of Clinical Oncology
    Desc: ASCO Journals Reviewer Mentoring Program
    Scope: National
    Date: 2021-01-01
    Org: Case Western Reserve University
    Desc: Research Award: Lung cancer genomics and racial disparity
    Scope: Department
    Date: 2019-04-01

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor